Clinical Trial Update: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating treatment for aggressive Adult T-cell leukemia/lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Adult T-cell Leukemia, Lymphoma | Phase 3 | Status: COMPLETED